Ecofinity Atomix Limited is an India-based company, which is focused on manufacturing pharmaceutical products. The Company, through its subsidiary, Padmavati Chemicals, is engaged in the business of manufacturing of chemical and its related products.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-07-31	₹67.90	+1.97%	11,531
26-07-30	₹66.59	+1.85%	17,589
26-07-29	₹65.38	+3.40%	26,717
26-07-28	₹63.23	+1.97%	31,655
26-07-27	₹62.01	+3.44%	15,252

Delayed Quote Bombay S.E.

More quotes

Income Statement and Estimates

More financial data

Market Closed - Bombay S.E. Other stock markets 06:00:58 2026-07-31 EDT			5-day change	1st Jan Change
67.90 ^INR	+1.97%		+13.26%	+58.98%

05-30	Ecofinity Atomix Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
02-14	Ecofinity Atomix Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Market Cap	365M 3.83M 3.33M 3.1M 2.84M 5.37M 5.45M 36.49M 14.32M 182M 14.37M 14.05M 610M	P/E 2024	52.4x	P/E 2025	14.3x
Enterprise Value	364M 3.81M 3.31M 3.08M 2.83M 5.35M 5.43M 36.35M 14.26M 181M 14.31M 14M 607M	EV / Sales 2024	2.14x	EV / Sales 2025	0.44x
Free-Float	40.3%	Yield 2024 *	-	Yield 2025	-

05-30	Ecofinity Atomix Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
02-14	Ecofinity Atomix Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-20	Ecofinity Atomix Limited Declares Interim Dividend for the Financial Year 2025 - 2026	CI
11-14	Ecofinity Atomix Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-08-13	Ecofinity Atomix Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-08-04	Ecofinity Atomix Limited Initiates to Setup Two Solar Plants Up to Total Capacity of 10,000 KW Solar PV System	CI
25-05-30	Ecofinity Atomix Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	CI
25-02-14	Ecofinity Atomix Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
24-12-05	Ecofinity Atomix Limited Appoints Ila Sunil Trivedi as the Chief Financial Officer	CI
24-12-03	Ecofinity Atomix Acquires 60% Stake in Padmavati Chemicals	MT
24-11-29	Ecofinity Atomix Limited announced that it has received INR 99.7425 million in funding from Thakurji International Private Limited	CI
24-10-30	Ecofinity Atomix Limited Announces Resignation of Manali Jadav as Chief Financial Officer	CI
24-10-30	Ecofinity Atomix Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI

1 day	+1.97%
1 week	+13.26%
1 month	+38.71%
3 months	+28.38%
6 months	+40.87%
Current year	+58.98%

Ecofinity Atomix Limited Stock

Stocks

ARYAVAN

INE360S01012

Pharmaceuticals

Valuation: Ecofinity Atomix Limited

Chart: Ecofinity Atomix Limited

Latest news : Ecofinity Atomix Limited

Quotes and Performance

Course Extremes

Managers and Directors: Ecofinity Atomix Limited

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	58.01	69.4
1 month	47.01	69.4
Current year	41	69.4
1 year	34.51	69.4
3 years	27.75	69.74
5 years	7.49	69.74
10 years	7.49	69.74

Manager	Title	Age	Since
Prafullchandra V. Patel CEO	Chief Executive Officer	62	2023-06-15
Ila Sunil Trivedi DFI	Director of Finance/CFO	49	2024-12-04
Rina Singh CMP	Compliance Officer	-	2024-05-31

Director	Title	Age	Since
Prafullchandra V. Patel CHM	Chairman	62	2023-06-15
Hirenkumar J. Patel BRD	Director/Board Member	40	2023-06-15
Jashvantbhai S. Patel BRD	Director/Board Member	73	2023-07-26

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ECOFINITY ATOMIX LIMITED	+1.97%	+13.26%	+19.16%	+144.68%	4.95M
ELI LILLY AND COMPANY	-0.53%	-3.95%	+55.23%	+152.74%	1,024B
JOHNSON & JOHNSON	+0.21%	-2.68%	+55.61%	+53.02%	618B
ABBVIE INC.	-2.51%	-3.25%	+32.76%	+67.76%	443B
ROCHE HOLDING AG	+0.06%	-0.42%	+37.53%	+30.67%	349B
NOVARTIS AG	-0.14%	-0.24%	+34.41%	+39.01%	297B
ASTRAZENECA PLC	-0.69%	-0.30%	+11.55%	+12.93%	264B
NOVO NORDISK A/S	-7.37%	-4.40%	-2.54%	-43.87%	209B
AMGEN INC.	-0.64%	+2.43%	+30.52%	+64.49%	208B
GILEAD SCIENCES, INC.	-0.82%	+0.70%	+15.96%	+71.01%	162B
Average	-1.05%	+0.25%	+29.02%	+59.25%	357.38B
Weighted average by Cap.	-0.99%	-1.93%	+39.24%	+72.95%

	2024	2025
Net sales	65.26M 684K 594K 553K 508K 959K 974K 6.52M 2.56M 32.49M 2.57M 2.51M 109M	360M 3.77M 3.28M 3.05M 2.8M 5.29M 5.37M 35.94M 14.1M 179M 14.15M 13.84M 600M
Net income	2.73M 28.59K 24.85K 23.13K 21.24K 40.1K 40.73K 273K 107K 1.36M 107K 105K 4.56M	13.49M 141K 123K 114K 105K 198K 201K 1.35M 529K 6.72M 531K 519K 22.52M
Net Debt	-3.41M -35.68K -31.02K -28.87K -26.51K -50.05K -50.83K -340K -134K -1.7M -134K -131K -5.69M	-1.43M -14.94K -12.99K -12.09K -11.1K -20.96K -21.28K -142K -55.92K -710K -56.1K -54.87K -2.38M